RedHill Biopharma (RDHL) Earnings
|
Expand Research on RDHL
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +15.8% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +16.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/18/21  |
 |
Q420 | $0.00 | -$0.24 | +$0.24 | N/A | $26.03M | N/A |  | | Details |
| 11/12/20 | |
Q320 | $0.05 | -$0.16 | +$0.21 | $20.9M | $25.37M | N/A | | | Details |
| 8/25/22 | Q222 | N/A | -$0.16 | N/A | N/A | $25.2M | N/A | N/A | N/A | ||
| 8/29/22 | Q222 | N/A | -$0.16 | N/A | N/A | $25.2M | N/A | N/A | N/A | ||
| 8/26/21 | |
Q221 | -$0.06 | -$0.12 | +$0.06 | $21.5M | $25.02M | N/A | | | Details |
| 11/30/21 | |
Q321 | -$0.05 | -$0.21 | +$0.16 | $21.6M | $24.52M | N/A | | | Details |
| 6/23/22 | |
Q122 | -$0.03 | -$0.23 | +$0.20 | $18.2M | $24.3M | N/A | | | Details |
| 3/17/22 | |
Q421 | $0.00 | -$0.33 | +$0.33 | $22.1M | $24.08M | N/A | | | Details |
